Malabar Investments Portfolio

The table below shows the Malabar Investments Portfolio based on the Highest Market Capitalization.

Content:

• What Is Malabar Investments?
• Top Malabar Investments Portfolio Stocks
• Best Malabar Investments Portfolio Stocks
• Malabar Investments Net Worth
• Performance Metrics Of Malabar Investments Portfolio Stocks
• How Do You Invest In Malabar Investments Portfolio Stocks?
• Benefits Of Investing In Malabar Investments Stock Portfolio Stocks
• Challenges Of Investing In Malabar Investments Portfolio Stocks
• Introduction To Malabar Investments Portfolio Stocks
  • Hatsun Agro Product Ltd
  • Affle (India) Ltd
  • Aptus Value Housing Finance India Ltd
  • Newgen Software Technologies Ltd
  • Aurionpro Solutions Ltd
  • Shilpa Medicare Ltd
  • JTEKT India Ltd
  • SBFC Finance Ltd
  • Supriya Lifescience Ltd
• Malabar Investments Portfolio Stocks – FAQs

What Is Malabar Investments?

Malabar Investments is an Indian investment management firm focused on long-term equity investments. The firm primarily invests in publicly listed small and mid-cap companies with strong growth potential. Known for its research-driven approach, Malabar Investments aims to generate sustainable returns for its investors through a diversified portfolio and strategic investment practices.

Top Malabar Investments Portfolio Stocks

The table below shows the Top Malabar Investments Portfolio Stocks based on 1 Year Return. 

Best Malabar Investments Portfolio Stocks

The table below shows the Best Malabar Investments Portfolio Stocks based on the highest day Volume.

Malabar Investments Net Worth

Malabar Investments is a prominent investment firm known for its strategic investments in high-growth companies. It specializes in public equity, managing a diverse portfolio across various sectors. With a strong focus on long-term value creation, the firm has a net worth of approximately ₹6,000 crores, reflecting its significant presence and influence in the investment landscape.

Performance Metrics Of Malabar Investments Portfolio Stocks

Performance Metrics of Malabar Investments Portfolio Stocks demonstrate strong potential due to their consistent performance across key fundamental metrics, ensuring a solid foundation for long-term growth and stability.

1. Earnings Growth: A steady increase in earnings showcases the company’s ability to generate higher profits over time.

2. Return on Equity (ROE): High ROE indicates efficient use of shareholders’ equity to generate profits.

3. Debt-to-Equity Ratio: A low ratio signifies a strong balance sheet with manageable debt levels, reducing financial risk.

4. Price-to-Earnings (P/E) Ratio: Competitive P/E ratio reflects a reasonable valuation relative to the company’s earnings, making it an attractive investment.

5. Dividend Yield: Consistent dividend payments highlight the company’s commitment to returning value to shareholders.

6. Cash Flow: Robust cash flow from operations ensures the company can sustain its growth and meet financial obligations without relying heavily on external financing.

How Do You Invest In Malabar Investments Portfolio Stocks?

To invest in Malabar Investments portfolio stocks, start by researching their portfolio holdings. Open a brokerage account if you don’t already have one. Look for the stocks listed in Malabar’s portfolio and purchase shares through your brokerage platform. Alternatively, consider investing in mutual funds or ETFs managed by Malabar Investments for a diversified approach and professional management.

Benefits Of Investing In Malabar Investments Stock Portfolio Stocks

The benefit of investing in Malabar Investments Stock Portfolio Stocks is that it offers a strategic advantage due to the firm’s track record of prudent and profitable investments, ensuring robust returns and a well-managed portfolio that appeals to both seasoned and new investors.

1. Diversification: Malabar Investments provides a diversified portfolio, reducing risk by investing across various sectors.

2. Expert Management: The portfolio is managed by experienced professionals with a deep understanding of market trends.

3. Consistent Performance: Historical data shows that Malabar Investments stocks have delivered consistent returns over the years.

4. Growth Potential: The portfolio includes high-growth potential stocks, offering significant capital appreciation opportunities.

5. Strong Financials: Companies in the Malabar Investments portfolio typically have strong financial health, ensuring stability and reliability for investors.

Challenges Of Investing In Malabar Investments Portfolio Stocks

Challenges of investing in Malabar Investments portfolio stocks arise from potential high volatility in certain sectors, which can result in unpredictable returns and heightened investment risk.

1. Concentration Risk: A significant portion of the portfolio might be invested in a few sectors, increasing the risk if those sectors underperform.

2. Market Timing: Accurately predicting the best times to buy or sell stocks can be difficult, leading to potential losses.

3. Economic Sensitivity: Stocks in the portfolio may be highly sensitive to economic changes, impacting their performance during economic downturns.

4. Liquidity Issues: Some stocks in the portfolio might have low trading volumes, making it challenging to buy or sell them without affecting the market price.

5. Regulatory Risks: Changes in government regulations and policies can impact the performance of certain stocks within the portfolio.

Introduction To Malabar Investments Portfolio Stocks

Malabar Investments Portfolio – Highest Market Capitalization

Hatsun Agro Product Ltd

The Market Cap of Hatsun Agro Product Ltd is Rs. 22,321.60 crores. The stock has a monthly return of 7.44%. Its one-year return is 18.48%. The stock is 12.99% away from its 52-week high.

Hatsun Agro Product Limited, an India-based company, processes and markets milk, milk products, and ice cream. The company’s operations are divided into the Milk & Milk Products segment. Its product range includes milk, curd, ice cream, dairy whitener, skimmed milk powder, ghee, and paneer, catering to cooking and consumption needs. The company’s well-known brands are Arun Icecreams, Arokya Milk, Ibaco, HAP Daily, Ibaco, and Santosa. 

Arun Icecreams offers various products such as Bars, Cups, and Tubs. Arokya provides standardized milk, curd, and paneer. Hatsun offers butter, ghee, curd, yogurt, and other dairy products. HAP daily carries brands like Arokya, Hatsun, and Arun Ice Creams. Ibaco specializes in ice cream, ice cream cakes, and yogurt shakes. Santosa offers products like Calf Starter Pellet and Santosa XL Pellet.

Affle (India) Ltd

The market cap of Affle (India) Ltd is Rs. 17,202.02 crore. The stock’s monthly return is 15.83%. Its one-year return is 25.08%. The stock is 6.53% away from its 52-week high.

Affle (India) Limited is a globally operating technology company specializing in providing a consumer intelligence platform for targeted mobile advertising. The company’s operations are divided into two main segments: the Consumer Platform and the Enterprise Platform. The Consumer Platform focuses on delivering personalized consumer recommendations and conversions through mobile advertising, aiding in user acquisition and engagement for various applications, businesses, and brands. 

On the other hand, the Enterprise Platform offers digital transformation services to create audience-centric digital assets. This includes Appnext, Jampp, MAAS, RevX, and Vizury. Additionally, Affle offers comprehensive solutions to help enterprises improve their engagement with mobile users, including app development and facilitating offline-to-online commerce initiatives for businesses transitioning into e-commerce.

Aptus Value Housing Finance India Ltd

The Market Cap of Aptus Value Housing Finance India Ltd is Rs. 15,453.22 crores. The stock’s monthly return is 7.96%. Its one-year return is 28.00%. The stock is 12.10% away from its 52-week high.

Aptus Value Housing Finance India Limited is an Indian company that primarily provides home loans. The company also offers loans for non-housing finance purposes, such as loans against properties (LAP), and insurance services. 

The company’s main goal is to meet its customers’ long-term housing finance needs. LAP products include LAP-Construction and LAP-Purchase, which are aimed at refinancing funds used for building or buying a house. Additionally, the company provides credit shield insurance, ensuring that the loan outstanding amount is repaid in the event of a customer’s death. Aptus Finance India Private Limited’s subsidiary operates as a non-banking finance company.

Top Malabar Investments Portfolio Stocks – 1-Year Return

Newgen Software Technologies Ltd

The Market Cap of Newgen Software Technologies Ltd is Rs. 12,393.53 crore. The stock’s monthly return is -1.87%. Its one-year return is 182.85%. The stock is 15.30% away from its 52-week high.

Newgen Software Technologies Limited, an India-based company, provides a digital transformation platform called NewgenONE that offers automated end-to-end processes, comprehensive content and communication management, AI-based cognitive features, governance, and a strong integration ecosystem. The core components of the NewgenONE platform include Contextual Content Services (ECM), Low Code Process Automation (BPM), Omnichannel Customer Engagement (CCM), and Artificial Intelligence Cloud. 

Newgen also offers low-code application platforms for enterprises to develop and deploy business applications in the cloud. The platform caters to various industries with applications ranging from onboarding to service requests, lending to underwriting, and more. The company operates in geographic segments such as India, Europe, Middle East, and Africa (EMEA), Asia Pacific and Australia (APAC), and the United States of America (USA).

Aurionpro Solutions Ltd

The Market Cap of Aurionpro Solutions Ltd is Rs. 6082.46 crore. The stock’s monthly return is 7.69%. Its one-year return is 182.47%. The stock is 3.77% away from its 52-week high.

Aurionpro Solutions Limited is a global technology company that provides a variety of solutions to a diverse client base, including major banks, financial institutions, governments, and businesses. The company’s main focus areas are Banking & Fintech and Technology Innovation. Within its Banking & Fintech division, it offers a Corporate Banking Suite comprising a transaction banking platform and a lending banking platform, with iCashpro+ being its transaction banking platform. 

Additionally, the company offers a customer experience platform called Aurionpro Customer Experience (ACE) that serves various industry sectors. In the Technology Innovation Group segment, Aurionpro provides solutions for Smart City initiatives, Smart Mobility, and Data centers, helping authorities transform cities into smart cities through digital governance and strategic planning. The company also operates the Interactive Communication Business (Interact DX).

Shilpa Medicare Ltd

The Market Cap of Shilpa Medicare Ltd is Rs. 4894.92 crores. The stock’s monthly return is 8.38%. Its one-year return is 124.82%. The stock is 5.36% away from its 52-week high.

Shilpa Medicare Limited is an Indian pharmaceutical company that focuses on research and development, manufacturing, and sales of oncology drugs and formulations. The company’s product range includes oncology and non-oncology active pharmaceutical ingredients (APIs), oncology formulations, biosimilars, ophthalmic products, oral dissolving films, biochemical diagnostics, organic intermediates, pilot and production scales, and transdermal patches. Shilpa Medicare Limited supplies oncology APIs and intermediates worldwide. 

Its oncology and non-oncology APIs are supplied to various regulated markets such as the United States, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. The company’s non-oncology APIs include Ambroxol in Europe and Tranexamic Acid and Ursodeoxycholic Acid in India. Shilpa Medicare Limited also manufactures and sells Lenvatinib Capsules under the brand name Lenshil.

Best Malabar Investments Portfolio Stocks – Highest Day Volume

JTEKT India Ltd

The Market Cap of JTEKT India Ltd is Rs. 4152.40 crores. The stock’s monthly return is 6.86%. Its one-year return is 34.41%. The stock is 0.85% away from its 52-week high.

JTEKT India Limited, an India-based company, specializes in manufacturing and assembling automotive components. Their product range includes rack and pinion steering systems, hydraulic power steering systems, column-type electric power steering systems, and driveline products. 

They also offer machine tools and bearings. The company serves as a tier 1 supplier to OEM customers, supplying automotive products to well-known manufacturers such as Maruti Suzuki, TATA Motors, Honda, Toyota Kirloskar, Renault Nissan, Mahindra & Mahindra, E-Z-Go Textron, Trenton Pressing LLC, Jtekt Column Systems, and France for both commercial and passenger vehicles on a business-to-business basis.

SBFC Finance Ltd

The Market Cap of SBFC Finance Ltd is Rs. 8944.91 crores. The stock’s monthly return is 4.02%. Its one-year return is -6.52%. The stock is 13.70% away from its 52-week high.

SBFC Finance Limited is a non-banking financial institution that specializes in providing secured loans to micro, small, and medium enterprises (MSMEs) as well as loans against gold. The majority of its borrowers consist of entrepreneurs, small business owners, self-employed individuals, salaried employees, and working-class individuals. The company has implemented a hybrid model, known as a PhyGital approach, which combines digital technology with personalized customer interactions to establish strong relationships with its clients. 

Additionally, it offers specialized loan management services to assist institutional lenders in overseeing various aspects of loan servicing such as client communication, collections, payments, data storage, and account transfers. Aside from directly offering customers loans, SBFC Finance Limited also provides Loan Management Services (LMS) to external financial institutions. This service includes facilitating the switch of repayment methods (NACH/ECS) and transferring monthly installment payments between accounts.  

Supriya Lifescience Ltd

The Market Cap of Supriya Lifescience Ltd is Rs. 2947.28 crore. The stock’s monthly return is 1.28%. Its one-year return is 64.78%. The stock is 6.44% away from its 52-week high.

Supriya Lifescience Limited is an Indian company specializing in producing active pharmaceutical ingredients (APIs). The company manufactures bulk drugs and pharmaceutical chemicals, exporting its products to approximately 86 countries in categories such as antihistamines, anesthetics, and anti-asthma therapies. 

With a product portfolio comprising around 38 niche API products, Supriya Lifescience Limited offers remedies in therapeutic segments like antihistamines, analgesics, vitamins, anesthetics, and anti-asthmatics. The company operates manufacturing facilities in Maharashtra and produces a range of products including chlorphenamine maleate, pheniramine maleate, and bronmpheniramine maleate.

Malabar Investments Portfolio Stocks – FAQs

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.